Bringing the fundamentals into focus…
Bringing the fundamentals into focus…
PCRX · against 1,372 other Healthcare companies
Ranked #463 of 1,373 · scores higher than 66% of peers · safety percentile 66
Bars: peers in each 10-point band of the safety percentile (higher = safer; 67+ earns the lower-risk grade)137 peers with a safety percentile of 60–69, including PCRX · Click a bar to see the companies
A mix: stronger current ratio and beta, but weaker debt / equity than most Healthcare peers.
Risk is relative to the sector, not a bankruptcy probability. Banks and brokers carry high leverage by design, and share buybacks can shrink equity and current assets, which raises debt/equity on paper.
| Metric | PCRX | Peer median | Better than | Position among peers | Weight |
|---|---|---|---|---|---|
| Debt / equityLower is better · 1,280 reported | 0.61× | 0.24× | 27% | 33% | |
| BetaLower is better · 1,320 reported | 0.25 | 0.53 | 73% | 33% | |
| Current ratioHigher is better · 1,338 reported | 5.04× | 2.62× | 74% | 33% |
| Rank | Company | Market cap | Safety | Overall |
|---|---|---|---|---|
| 1 | 5.6B USD | 100 | 53 | |
| 1 | 6.6B USD | 100 | 45 | |
| 3 | 186M USD | 100 | 52 | |
| 4 | 1.5B USD | 100 | 44 | |
| 5 | 1.2B USD | 100 | 40 | |
| 459 | 6.2B TWD (≈$193M) | 67 | 42 | |
| 460 | 9.3B CNY (≈$1.3B) | 67 | 56 | |
| 461 | 13.5B CNY (≈$1.9B) | 66 | 67 | |
| 462 | 3.2B CNY (≈$443M) | 66 | 27 | |
| 463 | 1.5B USD | 66 | 59 | |
| 464 | 871.6B INR (≈$10.5B) | 66 | 66 | |
| 465 | 9.3B AUD (≈$6.1B) | 66 | 55 | |
| 466 | 1.03T JPY (≈$7.0B) | 66 | 68 | |
| 467 | 4.3B CNY (≈$596M) | 66 | 56 |
Scores are sector-relative percentiles from the latest snapshot, always calculated against the whole sector: narrowing the comparison group changes who you compare with, not the scores. Missing metrics are left out and the remaining weights rescaled. How we score